Early Infant Diagnosis for Early Access to Care and Treatment
Studies show that, left unidentified and untreated, 50-60% of HIV-infected infants die by age two. CDC led the development of the Early Infant Diagnosis (EID) testing procedure that gives HIV-infected infants early access to diagnosis and appropriate care and treatment. With a simple prick of an infant’s heel, toe, or finger, blood is placed onto a card to dry, creating samples that remain stable for relatively long periods without refrigeration, making them simple to transport for testing. Infants can be diagnosed 4-6 weeks after HIV exposure with nearly 100% accuracy using this test. To ensure quality testing, a quality assurance program was developed and administered to 150 laboratories in 40 PEPFAR-supported countries.
Read more about CDC’s high quality laboratory systems at www.cdc.gov/globalaids/What-CDC-is-Doing/laboratories.html.